Last Posted: Aug 17, 2019
- A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients
H Shimizu et al, E Biomedicine, August 2019 - Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer.
Medford Arielle J et al. NPJ precision oncology 2019 18 - Mortality and Risk of Cancer After Prophylactic Bilateral Oophorectomy in Women With a Family History of Cancer.
Abildgaard Julie et al. JNCI cancer spectrum 2018 Jul 2(3) pky034 - Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study.
Schrijver Lieske H et al. JNCI cancer spectrum 2018 Apr 2(2) pky023 - The Real Impact of Target Therapy in Breast Cancer Patients: Between Hope and Reality.
Bordonaro Sebastiano et al. Current cancer drug targets 2018 18(5) 480-498 - Genetic Testing Can Reduce Suffering and Save Lives
L Corduck, AJMC, August 14, 2019 - Assessment of significant procedures in multigene molecular detection for breast cancer in clinical laboratories: from variant detection to targeted therapy.
Zhang Rui et al. Breast cancer (Tokyo, Japan) 2019 Aug - Barriers to the utilization of genetic testing and genetic counseling in patients with suspected hereditary breast and ovarian cancers.
Swink Alicia et al. Proceedings (Baylor University. Medical Center) 2019 Jul 32(3) 340-344 - Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
Lew Jie-Bin et al. Public health research & practice 2019 Jul 29(2) - Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Diagnosis.
Rodriguez Begona Jimenez et al. Journal of clinical medicine 2019 Aug 8(8)
.png)
No hay comentarios:
Publicar un comentario